PHARMESIS INTERNATIONAL LTD.

Transcripts Pharmesis International Ltd.

Equities

BFK

SG1BH6000003

Delayed Singapore S.E. Other stock markets 08:58:51 2024-04-28 pm EDT			5-day change	1st Jan Change
0.111 ^SGD	-7.50%		+38.75%	+13.27%

Apr. 29	Pharmesis International Ltd. Announces Retirement of Lin Yimin as Non-Independent Non-Executive Director and Member of Audit Committee	CI
Apr. 15	Pharmesis’ Attributable Loss for 2023 Widens	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Pharmesis International Ltd. Provides Earnings Guidance for the Second Half and Financial Year Ended 31 December 2021	22-02-21	CI
Pharmesis International Ltd. Provides Group Earnings Guidance for the Fourth Quarter and the Full Year Ended December 31, 2019	20-02-21	CI
Pharmesis International Ltd. Provides Un-Audited Group Earnings Guidance for the Third Quarter and Nine Months Ended September 30, 2019	19-11-04	CI
Pharmesis International Ltd. Provides Earnings Guidance for the Second Quarter and First Half of 2019	19-08-01	CI
Pharmesis International Ltd. Provides Unaudited Earnings Guidance for the First Quarter Ended March 31, 2019	19-05-08	CI
Pharmesis International Ltd. Provides Earnings Results Guidance for the Fourth Quarter and Financial Year 2018	19-02-25	CI
Pharmesis International Ltd. Provides Earnings Guidance for the Third Quarter Ended September 30, 2016	16-11-07	CI
Pharmesis International Ltd. Provides Earnings Guidance for the Second Quarter Ended 30 June 2016	16-08-05	CI
Pharmesis International Ltd. Provides Earnings Guidance for the First Quarter of 2016	16-05-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer